JP2013505429A5 - - Google Patents

Download PDF

Info

Publication number
JP2013505429A5
JP2013505429A5 JP2012529080A JP2012529080A JP2013505429A5 JP 2013505429 A5 JP2013505429 A5 JP 2013505429A5 JP 2012529080 A JP2012529080 A JP 2012529080A JP 2012529080 A JP2012529080 A JP 2012529080A JP 2013505429 A5 JP2013505429 A5 JP 2013505429A5
Authority
JP
Japan
Prior art keywords
icd
epex
level
detected
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012529080A
Other languages
English (en)
Japanese (ja)
Other versions
JP6048660B2 (ja
JP2013505429A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2010/001503 external-priority patent/WO2011032296A1/en
Publication of JP2013505429A publication Critical patent/JP2013505429A/ja
Publication of JP2013505429A5 publication Critical patent/JP2013505429A5/ja
Application granted granted Critical
Publication of JP6048660B2 publication Critical patent/JP6048660B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012529080A 2009-09-21 2010-09-21 甲状腺癌を診断および処置するための方法および組成物 Expired - Fee Related JP6048660B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24417309P 2009-09-21 2009-09-21
US61/244,173 2009-09-21
PCT/CA2010/001503 WO2011032296A1 (en) 2009-09-21 2010-09-21 Methods and compositions for the diagnosis and treatment of thyroid cancer

Publications (3)

Publication Number Publication Date
JP2013505429A JP2013505429A (ja) 2013-02-14
JP2013505429A5 true JP2013505429A5 (https=) 2013-11-14
JP6048660B2 JP6048660B2 (ja) 2016-12-21

Family

ID=43758006

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012529080A Expired - Fee Related JP6048660B2 (ja) 2009-09-21 2010-09-21 甲状腺癌を診断および処置するための方法および組成物

Country Status (7)

Country Link
US (1) US20120252022A1 (https=)
EP (1) EP2480687B1 (https=)
JP (1) JP6048660B2 (https=)
CN (1) CN102844443B (https=)
AU (1) AU2010295172B2 (https=)
CA (1) CA2773907A1 (https=)
WO (1) WO2011032296A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013025415B1 (pt) * 2011-04-01 2021-03-16 Immunogen, Inc uso de um imunoconjugado antirreceptor de folato 1 (folr1)
WO2012153186A2 (en) * 2011-05-06 2012-11-15 Kalgene Pharmaceuticals Inc. Monoclonal antibodies to epcam-icd and methods for detecting epithelial cancer cells
EP2541249A1 (en) * 2011-06-28 2013-01-02 Oncotyrol Center for Personalized Cancer Medicine GmbH EpCAM detection
EP2726870B1 (en) 2011-06-29 2018-10-03 Academia Sinica The capture, purification and release of biological substance using a surface coating
RU2485517C2 (ru) * 2011-12-13 2013-06-20 Федеральное Государственное Бюджетное Учреждение "Московский Научно-Исследовательский Онкологический Институт Им. П.А. Герцена Министерства Здравоохранения И Социального Развития России" Способ диагностики степени злокачественного рака щитовидной железы
EP2819695B1 (en) * 2012-03-02 2018-06-27 Academia Sinica ANTI-EPITHELIAL CELL ADHESION MOLECULE (EpCAM) ANTIBODIES AND METHODS OF USE THEREOF
CN104937111B (zh) 2012-11-27 2018-05-11 智利天主教教皇大学 用于诊断甲状腺肿瘤的组合物和方法
CN105431161A (zh) * 2013-02-21 2016-03-23 范安德尔研究所 Norrin突变体多肽、其制造方法和用途
EP2772758A1 (en) 2013-02-27 2014-09-03 Oncotyrol Center for Personalized Cancer Medicine GmbH EpCAM tumour diagnosis
TW201623605A (zh) 2014-04-01 2016-07-01 中央研究院 用於癌症診斷及預後之方法及系統
US10112198B2 (en) 2014-08-26 2018-10-30 Academia Sinica Collector architecture layout design
US10107726B2 (en) 2016-03-16 2018-10-23 Cellmax, Ltd. Collection of suspended cells using a transferable membrane
CN109187975A (zh) * 2018-08-08 2019-01-11 施康培医疗科技（武汉）有限公司 一种甲状腺髓样癌联合检测胶体金免疫层析试纸条
CN113631924A (zh) * 2019-05-24 2021-11-09 富士瑞必欧株式会社 甲状腺球蛋白的测定方法和测定试剂
CN110411992B (zh) * 2019-06-18 2022-05-06 山东省立医院 一种甲状腺组织结构的成像方法
CN115436640B (zh) * 2022-11-07 2023-04-18 西湖欧米(杭州)生物科技有限公司 适于可评估甲状腺结节恶性程度或概率的多肽的替代基质

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208020A (en) 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
US5474796A (en) 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5605662A (en) 1993-11-01 1997-02-25 Nanogen, Inc. Active programmable electronic devices for molecular biological analysis and diagnostics
US5312922A (en) 1992-04-06 1994-05-17 Nordion International Inc. Europium and terbium chelators for time-resolved fluorometric assays
US6015880A (en) 1994-03-16 2000-01-18 California Institute Of Technology Method and substrate for performing multiple sequential reactions on a matrix
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
AU5286999A (en) 1999-07-23 2001-02-13 Glaxo Group Limited Combination of an anti-ep-cam antibody with a chemotherapeutic agent
EP1383785B1 (en) 2001-05-03 2011-03-16 Merck Patent GmbH Recombinant tumor specific antibody and use thereof
US7256281B2 (en) * 2002-04-01 2007-08-14 United States Of America As Represented By The Secretary Of The Army Recombinant P. falciparum merozoite protein-142 vaccine
PL2382990T3 (pl) 2003-04-30 2015-04-30 Univ Zuerich Sposoby leczenia raka z zastosowaniem immunotoksyny
US20050180979A1 (en) * 2004-02-13 2005-08-18 Micromet Ag Anti-EpCAM immunoglobulins
CN101048426A (zh) * 2004-10-22 2007-10-03 金克克国际有限公司 分离人抗体
EP1874920A4 (en) * 2005-04-05 2009-11-04 Cellpoint Diagnostics DEVICES AND METHOD FOR ENRICHING AND CHANGING CIRCULATING TUMOR CELLS AND OTHER PARTICLES
WO2007008943A2 (en) 2005-07-08 2007-01-18 Xencor, Inc. Optimized anti-ep-cam antibodies
DK2041181T3 (da) * 2006-06-08 2011-08-29 Helmholtz Zentrum Muenchen Specifikke proteaseinhibitorer og deres anvendelse i cancerterapi

Similar Documents

Publication Publication Date Title
JP2013505429A5 (https=)
KR102648633B1 (ko) 암 예후 예측용 조성물
Min et al. S100A4 expression is associated with lymph node metastasis in papillary microcarcinoma of the thyroid
JP6743056B2 (ja) 前立腺がん予後判定の方法
JP6138154B2 (ja) 乳癌の予測および診断のためのバイオマーカー
JP6285009B2 (ja) 前立腺ガンの予後の検知及び判定のための組成物及び該検知及び判定方法
US20160168649A1 (en) Gene expression predictors of cancer prognosis
JP2008524998A5 (https=)
BR122020016370B1 (pt) métodos para predizer um resultado de câncer de mama em um tumor de mama positivo para receptor de estrogênio e negativo para her2 de um paciente com câncer de mama
CN106662543B (zh) 肺癌患者中的非侵入性基因突变检测
KR20140024907A (ko) 폐암용 바이오마커
McKelvie et al. The prognostic significance of the BRAFV600E mutation in papillary thyroid carcinoma detected by mutation-specific immunohistochemistry
DK3141617T3 (en) PROCEDURE FOR PREVENTING THE CANCER OF A CANCER ON A PATIENT BY ANALYZING GENEPRESSION
JP2015501151A (ja) 前立腺癌の分類のためのマーカー遺伝子
JP2011526487A (ja) 乳癌のゲノムフィンガープリント
CN108738329A (zh) 前列腺癌预后方法
US9777334B2 (en) Cancer blood test using BC200 RNA isolated from peripheral blood for diagnosis and treatment of invasive breast cancer
WO2015172201A1 (en) Biomarker of gastric cancer
EP1682679B1 (en) Molecular marker
EP2083087B1 (en) Method for determining tongue cancer
EP3426797A1 (en) Method for determining the risk of recurrence of an estrogen receptor-positive and her2-negative primary mammary carcinoma under an endocrine therapy
CN105063049A (zh) 用于肝癌预后评估的微小核酸序列、探针以及试剂盒
US20150329914A1 (en) Predictive biomarkers for pre-malignant breast lesions
US20240301506A1 (en) Ex vivo method for the prognosis of metastasis in prostate cancer
WO2019065609A1 (ja) Ｐｒｄｍ１４発現を確認する方法